RAE1 is a prognostic biomarker and is correlated with clinicopathological characteristics of patients with hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a primary malignant tumor that accounts for approximately 90% of all cases of primary liver cancer worldwide. Microtubule alterations may contribute to the broad spectrum of resistance to chemotherapy, tumor development, and cell survival. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Gang, Pei, Jin-Hong, Li, Xue-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233330/
https://www.ncbi.nlm.nih.gov/pubmed/35751040
http://dx.doi.org/10.1186/s12859-022-04806-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233330/
https://www.ncbi.nlm.nih.gov/pubmed/35751040
http://dx.doi.org/10.1186/s12859-022-04806-8

Ejemplares similares